Radiotherapy for pituitary adenomas: Long-term efficacy and toxicity

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 597-601

  Erridge, Sara C ^a,d   Conkey, David S ^b   Stockton, Diane ^c   Strachan, Mark W J ^a   Statham, Patrick F X ^a   Whittle, Ian R ^a   Grant, Robin ^a   Kerr, Gillian R ^d   Gregor, Anna ^a,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c INFORMATION SERVICES DIVISION   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cerebrovascular disease; Pituitary adenoma; Radiotherapy; Second cancer; Toxicity

Indexed keywords

CORTICOTROPIN; THYROTROPIN;

ADOLESCENT; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; INTRACRANIAL TUMOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; STROKE;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PITUITARY NEOPLASMS; RADIATION INJURIES; SURVIVAL RATE; YOUNG ADULT;

EID: 70449644866     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.09.011     Document Type: Article

References (22)

1. Brada M., Rajan B., Traish D., et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 38 (1993) 571-578
2. Dekkers O.M., Pereira A.M., Roelfsema F., et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91 (2006) 1796-1801
3. Greenman Y., Ouaknine G., Veshchev I., et al. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol 58 (2003) 763-769
4. Minniti G., Traish D., Ashley S., Gonsalves A., and Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90 (2005) 800-804
5. Fisher B.J., Gaspar L.E., and Noone B. Radiation therapy of pituitary adenoma: delayed sequelae. Radiology 187 (1993) 843-846
6. MacDougall R., Kerr G., and Duncan W. Incidence of sarcoma in patients treated with fast neutrons. Int J Radiat Oncol Biol Phys 66 (2006) 824
7. Becker G., Kocher M., Kortmann R.D., et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 178 (2002) 173-186
8. Brada M., and Jankowska P. Radiotherapy for pituitary adenomas. Endocrinol Metab Clin North Am 37 (2008) 263-275
9. Snead F., Amdur R., Morris C., and Mendenhall W. Long-term outcomes of radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 71 (2008) 994-998
10. Loeffler J.S., and Nachtigall L.B. Is fractionated stereotactic radiotherapy effective in pituitary adenomas?. Nat Clin Pract Oncol 2 (2005) 548-549
11. Voges J., Kocher M., Runge M., et al. Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107 (2006) 1355-1364
12. Mackley H.B., Reddy C.A., Lee S.Y., et al. Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland clinic experience. Int J Radiat Oncol Biol Phys 67 (2007) 232-239
13. Gittoes N.J., Bates A.S., Tse W., et al. Radiotherapy for non-function pituitary tumours. Clin Endocrinol 48 (1998) 331-337
14. van den Bergh A.C., van den Berg G., Schoorl M.A., et al. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 67 (2007) 863-869
15. Turner H., Stratton I., Byrne J., Adams C., and Wass J. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clin Endocrinol 51 (1999) 281-284
16. Littley M., Shalet S., Beardwell C., Robinson E., and Sutton M. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol 31 (1989) 363-373
17. McCollough W.M., Marcus Jr. R.B., Rhoton Jr. A.L., Ballinger W.E., and Million R.R. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy. Int J Radiat Oncol Biol Phys 21 (1991) 607-614
18. Tsang R.W., Brierley J.D., Panzarella T., et al. Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30 (1994) 557-565
19. Brada M., Ashley S., Ford D., et al. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol 57 (2002) 713-717
20. Holmer H., Svensson J., Rylander L., et al. Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone. J Clin Endocrinol Metab 92 (2007) 3560-3567
21. Tomlinson J.W., Holden N., Hills R.K., Wheatley K., Clayton R.N., Bates A.S., Sheppard M.C., and Stewart P.M. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357 (2001) 425-431
22. Norberg L., Johansson R., and Rasmuson T. Pituitary adenomas in norther Sweden: a study on therapy choices and the risk of second primary tumours. Clin Endocrinol 68 (2007) 780-785